- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02858427
Cognitive Inhibition, Psychosocial Interactions and Suicide Attempt in Elderly (OBSUIVAL)
Cognitive Inhibition Impairment and Suicide Attempt in Elderly: Eye Tracking Characterization and Impact of Psychosocial Interactions
Study Overview
Status
Conditions
Detailed Description
2 groups of patients will be studied: in the first group, depressed patients with a history of suicide attempt will be included whereas in the second group, depressed patients without a history of suicide attempt will be included.
For each group, the cognitive inhibition will be assessed trough an eye tracker task (antisaccade).
Both groups will also be compared on their neuropsychological characteristics and the quality of social interactions of participants.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: julie monnin, PhD
- Phone Number: 0033381218543
- Email: jmonnin@chu-besancon.fr
Study Contact Backup
- Name: Kristina Mouyabi
- Phone Number: 0033381218356
- Email: kmouyabi@chu-besancon.fr
Study Locations
-
-
-
Bavilliers, France
- Not yet recruiting
- CHS Bavilliers
-
Contact:
- Julie MONNIN, PhD
- Email: jmonnin@chu-besancon.fr
-
Principal Investigator:
- Caroline Masse-Sibille, MD
-
-
Doubs
-
Besancon, Doubs, France, 25030
- Recruiting
- CHU Besançon
-
Contact:
- Julie Monnin, PhD
- Phone Number: 00033381218543
- Email: jmonnin@chu-besancon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- major depressive disorder according to Diagnostic ans Statistical Manual (DSM) V
- group 1: with a history of suicide attempt
- group 2: without a history of suicide attempt
Exclusion Criteria:
- other psychiatric disease
- guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: depressed with suicide attempt (SA)
elderly depressed patients with a history of suicide attempt.
interventions: eye tracking, neuropsychological assessment, psychiatric assessment and sociological interview.
|
several oculomotor parameters will be recorded using vide-oculography techniques (eye tracking) trough different tasks: saccade, antisaccade, and picture scanning. Saccade task: the patient is looking at a screen and is asked to fix his gaze as quickly and accurately as possible on the red dot appearing on the periphery of the screen. Prosaccade task: the patient is looking at a screen and is asked to fix his gaze as quickly and accurately as possible on the opposite side relative to the red dot appearing on the periphery of the screen. Picture Scanning: participant is instructed to freely watch pictures with different emotional valence.
the neuropsychological assessment aims to identify any impairment of executive functioning through several tasks: Mini mental state examination (mmse), isaac set test (STI) trail making test (TMT A and B), Grober test, Stroop test, verbal fluency, Go No Go task, memory impairment screen (MIS), picture naming test (DO30), copying figure test, digit span and categorical matching test.
this evaluation aims to characterize the mental status of the patient.
Different scales will be used: Montgomery and ASberg depression rating scale (MADRS), Columbia-suicide severity rating scale (C-SSRS), Beck depression inventory (BDI), Barratt impulsiveness scale (BIS-10), Buss and Durkee Hostility Inventory (BDHI), Balloon, analogue risk task (BART), Iowa gambling task (IGT), and Childhood trauma questionnaire (CTQ).
this interview aims to characterize social interactions of the patients, their duration, their evolution and the perception of each participant on this subject.
|
Experimental: depressed without a history of SA
elderly depressed patients without a history of suicide attempt.
interventions: eye tracking, neuropsychological assessment, psychiatric assessment and sociological interview.
|
several oculomotor parameters will be recorded using vide-oculography techniques (eye tracking) trough different tasks: saccade, antisaccade, and picture scanning. Saccade task: the patient is looking at a screen and is asked to fix his gaze as quickly and accurately as possible on the red dot appearing on the periphery of the screen. Prosaccade task: the patient is looking at a screen and is asked to fix his gaze as quickly and accurately as possible on the opposite side relative to the red dot appearing on the periphery of the screen. Picture Scanning: participant is instructed to freely watch pictures with different emotional valence.
the neuropsychological assessment aims to identify any impairment of executive functioning through several tasks: Mini mental state examination (mmse), isaac set test (STI) trail making test (TMT A and B), Grober test, Stroop test, verbal fluency, Go No Go task, memory impairment screen (MIS), picture naming test (DO30), copying figure test, digit span and categorical matching test.
this evaluation aims to characterize the mental status of the patient.
Different scales will be used: Montgomery and ASberg depression rating scale (MADRS), Columbia-suicide severity rating scale (C-SSRS), Beck depression inventory (BDI), Barratt impulsiveness scale (BIS-10), Buss and Durkee Hostility Inventory (BDHI), Balloon, analogue risk task (BART), Iowa gambling task (IGT), and Childhood trauma questionnaire (CTQ).
this interview aims to characterize social interactions of the patients, their duration, their evolution and the perception of each participant on this subject.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
antisaccade error rate
Time Frame: 1 month max. after inclusion
|
1 month max. after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
saccade accuracy
Time Frame: 1 month max. after inclusion
|
distance between the eye position at the end of the first saccade, and the ideal position to engage the target in central vision
|
1 month max. after inclusion
|
saccadic intrusion
Time Frame: 1 month max. after inclusion
|
gaze deviation into a saccade greater than 3° during visual fixation
|
1 month max. after inclusion
|
maximal speed of the gaze
Time Frame: 1 month max. after inclusion
|
maximum speed of visual tracking without triggering any saccade
|
1 month max. after inclusion
|
saccade reaction time
Time Frame: 1 month max. after inclusion
|
1 month max. after inclusion
|
|
fixation duration on pictures
Time Frame: 1 month max. after inclusion
|
1 month max. after inclusion
|
|
social interaction quality score
Time Frame: 6 month max. after inclusion
|
6 month max. after inclusion
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
neuropsychological test score
Time Frame: 1 month max. after inclusion
|
1 month max. after inclusion
|
Collaborators and Investigators
Investigators
- Principal Investigator: pierre Vandel, MD PhD, Centre Hospitalier Universitaire de Besançon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P/2016/288
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Vestre Viken Hospital TrustSouth-Eastern Norway Regional Health AuthorityRecruitingEcological Momentary Assessment | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionNorway
-
Mental Health Services in the Capital Region, DenmarkCompletedSuicide Prevention | Suicidal Thoughts | Suicide AttemptsDenmark
-
Franciscan Hospital For Children, INC.National Institute of Mental Health (NIMH); Harvard UniversityRecruitingSuicidal Ideation | Self-Injurious Behavior | Suicide AttemptsUnited States
-
Boston UniversityUnited States Department of Defense; The University of Texas Health Science... and other collaboratorsNot yet recruiting
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Henry Ford Health System; HealthPartners...Enrolling by invitationSuicide, Attempted | Suicide, FatalUnited States
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
Clinical Trials on eye tracking
-
Institut National de la Santé Et de la Recherche...CompletedHealthy | Parkinson Disease | DystoniaFrance
-
Innodem NeurosciencesSyneos HealthRecruiting
-
Innodem NeurosciencesNovartis PharmaceuticalsRecruitingMultiple SclerosisCanada
-
McGill UniversityInnodem NeurosciencesRecruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisCanada
-
University Hospitals Cleveland Medical CenterRecruitingBipolar DisorderUnited States
-
Innodem NeurosciencesSuspendedNeurological DisordersCanada
-
Instituto Universitario de Oftalmobiología Aplicada...Hospital del Río Hortega; Hospital Clínico Universitario de ValladolidCompletedMultiple Sclerosis | Eye Abnormalities | Parkinson Disease | Ataxia, Cerebellar | Injury BrainSpain
-
Innodem NeurosciencesNot yet recruiting
-
Innodem NeurosciencesRecruitingMultiple SclerosisCanada
-
Innodem NeurosciencesRecruitingCancer-related Cognitive ImpairmentCanada